Influence of Lychnis chalcedonica L. Flavonoids on Transplanted Tumor Development and Cytostatic Therapy Effectiveness in Mice
- Авторлар: Amosova E.N.1, Zueva E.P.1, Lopatina K.A.1,2, Safonova E.A.1,2, Razina T.G.1, Rybalkina O.Y.1,2, Zibareva L.N.2
-
Мекемелер:
- E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
- Tomsk State University
- Шығарылым: Том 53, № 5 (2019)
- Беттер: 454-457
- Бөлім: Medicinal Plants
- URL: https://ogarev-online.ru/0091-150X/article/view/245806
- DOI: https://doi.org/10.1007/s11094-019-02018-8
- ID: 245806
Дәйексөз келтіру
Аннотация
A complex of biologically active compounds was isolated from Lychnis chalcedonica L. cultivated at the Siberian Botanical Garden at Tomsk State University. HPLC analysis found that the isolated compounds were flavonoids with retention times 10.40, 12.45, 13.29, and 15.47 min. The major flavonoid constituent was vicenin with tr = 13.29 min and a peak area of 87.4%. The flavonoid complex of L. chalcedonica was studied using three transplanted tumor models, i.e., Lewis lung carcinoma (LLC), melanoma B-16 (B-16), and lung cancer RL-67 (RL-67). Tests on C57BL/6 mice showed that the L. chalcedonica flavonoid complex inhibited development of melanoma B-16. Co-administration of L. chalcedonica flavonoids and cyclophosphamide enhanced the antitumor effect of the cytostatic in animals with B-16, RL-67, and LLC.
Негізгі сөздер
Авторлар туралы
E. Amosova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: zep0929@mail.ru
Ресей, 3 Prosp. Lenina, Tomsk, 634028
E. Zueva
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Хат алмасуға жауапты Автор.
Email: zep0929@mail.ru
Ресей, 3 Prosp. Lenina, Tomsk, 634028
K. Lopatina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State University
Email: zep0929@mail.ru
Ресей, 3 Prosp. Lenina, Tomsk, 634028; 36 Prosp. Lenina, Tomsk, 634050
E. Safonova
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State University
Email: zep0929@mail.ru
Ресей, 3 Prosp. Lenina, Tomsk, 634028; 36 Prosp. Lenina, Tomsk, 634050
T. Razina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences
Email: zep0929@mail.ru
Ресей, 3 Prosp. Lenina, Tomsk, 634028
O. Rybalkina
E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine, Tomsk National Research Medical Center, Russian Academy of Sciences; Tomsk State University
Email: zep0929@mail.ru
Ресей, 3 Prosp. Lenina, Tomsk, 634028; 36 Prosp. Lenina, Tomsk, 634050
L. Zibareva
Tomsk State University
Email: zep0929@mail.ru
Ресей, 36 Prosp. Lenina, Tomsk, 634050
Қосымша файлдар
